306 related articles for article (PubMed ID: 30646849)
1. Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study.
van Amerongen R; Gazendam RP; van Bergen JEAM
BMC Fam Pract; 2019 Jan; 20(1):12. PubMed ID: 30646849
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of chlamydia and gonorrhoea in general practice in England 2000-2011: a population-based study using data from the UK Clinical Practice Research Datalink.
Wetten S; Mohammed H; Yung M; Mercer CH; Cassell JA; Hughes G
BMJ Open; 2015 Apr; 5(5):e007776. PubMed ID: 26022269
[TBL] [Abstract][Full Text] [Related]
3. Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report.
van Dam AP; van Ogtrop ML; Golparian D; Mehrtens J; de Vries HJ; Unemo M
Sex Transm Infect; 2014 Nov; 90(7):513-4. PubMed ID: 25114322
[TBL] [Abstract][Full Text] [Related]
4. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
[TBL] [Abstract][Full Text] [Related]
5. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.
Korting HC; Abeck D
Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041
[TBL] [Abstract][Full Text] [Related]
6. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands.
de Vries HJ; van der Helm JJ; Schim van der Loeff MF; van Dam AP
Euro Surveill; 2009 Sep; 14(37):. PubMed ID: 19761737
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
[TBL] [Abstract][Full Text] [Related]
9. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.
Bignell C; Unemo M;
Int J STD AIDS; 2013 Feb; 24(2):85-92. PubMed ID: 24400344
[TBL] [Abstract][Full Text] [Related]
10. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
[TBL] [Abstract][Full Text] [Related]
11. Gonorrhoea in 21st century--international and Polish situation.
Serwin AB; Koper M; Unemo M
Przegl Epidemiol; 2014; 68(1):39-44, 127-31. PubMed ID: 25004630
[TBL] [Abstract][Full Text] [Related]
12. Low gonorrhoea antimicrobial resistance and culture positivity rates in general practice: a pilot study.
Visser M; van Westreenen M; van Bergen J; van Benthem BHB
Sex Transm Infect; 2020 May; 96(3):220-222. PubMed ID: 31040250
[TBL] [Abstract][Full Text] [Related]
13. Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?
Unemo M; Brooks B; Cole M; Ross JD; White JA; Patel R;
Int J STD AIDS; 2013 Jun; 24(6):423-6. PubMed ID: 23970742
[TBL] [Abstract][Full Text] [Related]
14. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associatedwith non-compliant prescribing: findings form a cross-sectional study.
Tisler-Sala A; Ojavee SE; Uusküla A
Sex Transm Infect; 2018 Jun; 94(4):298-303. PubMed ID: 29066628
[TBL] [Abstract][Full Text] [Related]
16. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
Hustig A; Bell C; Waddell R
Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
[TBL] [Abstract][Full Text] [Related]
17. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
[TBL] [Abstract][Full Text] [Related]
18. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
[TBL] [Abstract][Full Text] [Related]
19. [Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 1: Gonococci].
Nenoff P; Manos A; Ehrhard I; Krüger C; Paasch U; Helmbold P; Handrick W
Hautarzt; 2017 Jan; 68(1):43-49. PubMed ID: 27981386
[TBL] [Abstract][Full Text] [Related]
20. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
McCormack WM; Mogabgab WJ; Jones RB; Hook EW; Wendel GD; Handsfield HH
Sex Transm Dis; 1993; 20(5):269-73. PubMed ID: 8235924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
